Clariane SEXPAR:CLARI +2.16%61 Operating Margin % is 5.17% as of Dec. 2025, which is 33% below its 10-year median of 7.68. GuruFocus rates XPAR:CLARI with a GF Score™ of 61/100 and a GF Value™ of €2.49 (Significantly Overvalued). The stock has 9 warning signs investors should review. Among 668 Healthcare Providers & Services companies, Clariane SE ranks better than 52.84% on this metric.
Operating Margin % is calculated as Operating Income divided by its Revenue. Clariane SE's Operating Income for the
six
months ended in Dec. 2025 was €137 Mil. Clariane SE's Revenue for the
six
months ended in Dec. 2025 was €2,655 Mil. Therefore, Clariane SE's Operating Margin % for the quarter that ended in Dec. 2025 was 5.17%.
Warning Sign:
Clariane SE operating margin has been in a 5-year decline. The average rate of decline per year is -3.8%.
The historical rank and industry rank for Clariane SE's Operating Margin % or its related term are showing as below:
XPAR:CLARI'
s Operating Margin % Range Over the Past 10 Years
Min: 4.79 Med: 7.68 Max: 9.82
Current: 5.35
XPAR:CLARI's Operating Margin % is ranked better than 52.84% of 668
companies
in the Healthcare Providers & Services industry
Industry Median: 4.845
vs XPAR:CLARI: 5.35
Clariane SE's 5-Year Average Operating Margin % Growth Rate was -3.80% per year.
Clariane SE's Operating Income for the
six
months ended in Dec. 2025 was €137 Mil.
Its Operating Income for the trailing twelve months (TTM) ended in Dec. 2025 was €284 Mil.
Clariane SE (XPAR:CLARI) Operating Margin % Explanation
Just like Gross Margin %, it is important to see a company maintains its operating margin over time. Among the same industry, a company with higher operating margin is more efficient in its operation. It is also more stable during industry slowdown or recessions. Peter Lynch prefers those with higher margins than those with lower margins.
Be Aware
Operating Margin % can be manipulated by adjusting the rate of depreciation, depletion and amortization (DDA).
If a company is facing competition, its Operating Margin % may decline. Often the Operating Margin % declines well before the company's Revenue or even profit decline. Therefore, Operating Margin % is a very important indicator of whether the company is facing problems.
For instance, by 2012, Nokia (NOK)'s problems were well known and its stock had lost more than 90% of its market value since 2007. But Nokias Operating Margin % had already been in decline since 2002, although its Earnings per Share (Diluted) were still rising. Investors who paid attention to Operating Margin % would have avoided this huge loss. The same can be said for Research-in-Motion (RIMM).
Therefore, Operating Margin % is a very important screening filter for GuruFocus. GuruFocus's Buffett-Munger screener requires that the profit margin is either consistent or expanding. The Model Portfolio of the Buffett-Munger screener has outperformed the market every year since inception in 2009.
Clariane SE Operating Margin % Related Terms
Clariane SE Operating Margin % Historical Data
* Premium members only.
The historical data trend for Clariane SE's Operating Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XPAR:CLARI vs HCA, THC, DVA: Operating Margin % Comparison
For the Medical Care Facilities subindustry, Clariane SE's Operating Margin %, along with its competitors' market caps and Operating Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Clariane SE Operating Margin % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Clariane SE's Operating Margin % distribution charts can be found below:
* The bar in red indicates where Clariane SE's Operating Margin % falls into.
Operating Margin % - also known as operating income margin, operating profit margin and return on sales (ROS) - is the ratio of Operating Income divided by net sales or Revenue, usually presented in percent.
Clariane SE's Operating Margin % for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Clariane SE (XPAR:CLARI) has a Operating Margin % of 5.17% as of Dec. 2025. Operating margin is the ratio of total operating income to net sales. View historical data on Clariane SE and its competitors. This is 33% below median its historical median of 7.68. Over the past decade, Clariane SE's Operating Margin % has ranged from 4.79 to 9.82. According to the industry distribution chart, Clariane SE ranks #315 out of 668 companies in the Healthcare Providers & Services industry, placing it in the top 47.2%.
Is Clariane SE's Operating Margin % too high?
Clariane SE's current Operating Margin % of 5.17% is 33% below median its 10-year median of 7.68. Over the past 10 years, this metric has ranged from a low of 4.79 to a high of 9.82. The Healthcare Providers & Services industry median Operating Margin % is 4.85. Clariane SE's value of 5.17% is 6.7% above this industry median. Based on the distribution chart, Clariane SE ranks #315 out of 668 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Clariane SE has a GF Score™ of 61/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Clariane SE's Operating Margin % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Clariane SE ranks #315 out of 668 companies for Operating Margin %. This puts Clariane SE in the upper half of its industry. The industry median Operating Margin % is 4.85. Clariane SE's value of 5.17% is 6.7% above this benchmark. Historically, Clariane SE's own Operating Margin % has ranged from 4.79 to 9.82 over the past decade. While the company's 10-year median is 7.68 vs. the industry median of 4.85, Clariane SE has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Operating Margin % for a Healthcare Providers & Services company?
The median Operating Margin % among Healthcare Providers & Services companies is 4.85, based on 668 companies in the industry. Companies in the top quartile (top 25%) have a Operating Margin % significantly above this median, while those in the bottom quartile fall well below. However, Operating Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Clariane SE's current Operating Margin % of 5.17% is 6.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Operating Margin % mean?
A high Operating Margin % can signal that a stock is expensive relative to its fundamentals. Operating margin is the ratio of total operating income to net sales. View historical data on Clariane SE and its competitors. For the Healthcare Providers & Services industry, the median Operating Margin % is 4.85 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Clariane SE's current Operating Margin % is 5.17%, which is 33% below median its own 10-year median of 7.68. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Clariane SE stock overvalued right now?
Based on GuruFocus' analysis, Clariane SE (XPAR:CLARI) is currently considered Significantly Overvalued. The stock's GF Value™ is €2.49, compared to a current price of €4.25 — trading 70.7% above its estimated fair value. The current Operating Margin % is 5.17%, which is 33% below median its 10-year median of 7.68 and 6.7% above the Healthcare Providers & Services industry median of 4.85. Clariane SE's overall GF Score™ is 61/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Operating Margin % calculated?
Operating Margin % is calculated from a company's financial statements. For Clariane SE (XPAR:CLARI), the current Operating Margin % is 5.17% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Clariane SE (XPAR:CLARI) Overvalued in 2026?
Based on GuruFocus' analysis, Clariane SE stock appears to be overvalued.
The current stock price of €4.25 is trading 70.7% above its estimated GF Value™ of €2.49.
GuruFocus considers Clariane SE to be Significantly Overvalued.
Key valuation signals for XPAR:CLARI:
Operating Margin %: 5.17% (33% below median its 10-year median of 7.68)
GF Value™: €2.49 vs. price of €4.25 (70.7% above fair value)
Industry Position: 6.7% above the Healthcare Providers & Services median (#315 of 668)
No single metric tells the full story. See the XPAR:CLARI stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Clariane SE is a specialist in non-acute care and operates in two main areas: long-term care, through two forms of support, medicalized nursing homes offering specialty facilities accommodation and care for vulnerable older people and alternative living solutions, and specialty care activities such as specialty and post-acute , mental health and a number of medical, surgical and obstetrics clinics. Its segments include France, Germany, Benelux, Italy and Spain.
61GF Score
Get the complete analysis for XPAR:CLARI
Operating Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XPAR:CLARI has been successfully added to your 
